Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Current Taxes: 2017-2018

  • Akebia Therapeutics' Current Taxes was N/A to $987,000 in Q1 2018 from the same period last year, while for Mar 2018 it was $987,000, marking a year-over-year change of. This contributed to the annual value of $987,000 for FY2017, which is N/A change from last year.
  • Latest data reveals that Akebia Therapeutics reported Current Taxes of $987,000 as of Q1 2018, which was down 0.00% from $987,000 recorded in Q4 2017.
  • In the past 5 years, Akebia Therapeutics' Current Taxes registered a high of $987,000 during Q4 2017, and its lowest value of $987,000 during Q4 2017.
  • Its 2-year average for Current Taxes is $987,000, with a median of $987,000 in 2018.